Global Vaccine Delivery Devices Market Insights, Forecast to 2025

2 Global Vaccine Delivery Devices Quarterly Market Size Analysis

• 2.1 Vaccine Delivery Devices Business Impact Assessment - COVID-19
  • 2.1.1 Global Vaccine Delivery Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
  • 2.1.2 Global Vaccine Delivery Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Vaccine Delivery Devices Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 Global Vaccine Delivery Devices Quarterly Market Size by Manufacturers, 2019 VS 2020
• 3.2 Global Vaccine Delivery Devices Factory Price by Manufacturers
• 3.3 Location of Key Manufacturers Vaccine Delivery Devices Manufacturing Factories and Area Served
• 3.4 Date of Key Manufacturers Enter into Vaccine Delivery Devices Market
• 3.5 Key Manufacturers Vaccine Delivery Devices Product Offered
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Vaccine Delivery Devices Segments, By Type

• 4.1 Introduction
  • 1.4.1 Syringes
  • 1.4.2 Jet Injectors
  • 1.4.3 Other Devices
• 4.2 By Type, Global Vaccine Delivery Devices Market Size, 2019-2021
  • 4.2.1 By Type, Global Vaccine Delivery Devices Market Size by Type, 2020-2021
  • 4.2.2 By Type, Global Vaccine Delivery Devices Price, 2020-2021

5 Impact of Covid-19 on Vaccine Delivery Devices Segments, By Application

• 5.1 Overview
  • 5.5.1 Intradermal Vaccination
  • 5.5.2 Intramuscular Vaccination
  • 5.5.3 Subcutaneous Vaccination
  • 5.5.4 Others
• 5.2 By Application, Global Vaccine Delivery Devices Market Size, 2019-2021
  • 5.2.1 By Application, Global Vaccine Delivery Devices Market Size by Application, 2019-2021
  • 5.2.2 By Application, Global Vaccine Delivery Devices Price, 2020-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Becton Dickinson & Company
  • 7.1.1 Becton Dickinson & Company Business Overview
  • 7.1.2 Becton Dickinson & Company Vaccine Delivery Devices Quarterly Production and Revenue, 2020
  • 7.1.3 Becton Dickinson & Company Vaccine Delivery Devices Product Introduction
  • 7.1.4 Becton Dickinson & Company Response to COVID-19 and Related Developments
• 7.2 Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
  • 7.2.1 Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.) Business Overview
  • 7.2.2 Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.) Vaccine Delivery Devices Quarterly Production and Revenue, 2020
  • 7.2.3 Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.) Vaccine Delivery Devices Product Introduction
  • 7.2.4 Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.) Response to COVID-19 and Related Developments
• 7.3 PharmaJet; Vaxxas
  • 7.3.1 PharmaJet; Vaxxas Business Overview
  • 7.3.2 PharmaJet; Vaxxas Vaccine Delivery Devices Quarterly Production and Revenue, 2020
  • 7.3.3 PharmaJet; Vaxxas Vaccine Delivery Devices Product Introduction
  • 7.3.4 PharmaJet; Vaxxas Response to COVID-19 and Related Developments
• 7.4 Gerresheimer AG
  • 7.4.1 Gerresheimer AG Business Overview
  • 7.4.2 Gerresheimer AG Vaccine Delivery Devices Quarterly Production and Revenue, 2020
  • 7.4.3 Gerresheimer AG Vaccine Delivery Devices Product Introduction
  • 7.4.4 Gerresheimer AG Response to COVID-19 and Related Developments
• 7.5 Schott AG
  • 7.5.1 Schott AG Business Overview
  • 7.5.2 Schott AG Vaccine Delivery Devices Quarterly Production and Revenue, 2020
  • 7.5.3 Schott AG Vaccine Delivery Devices Product Introduction
  • 7.5.4 Schott AG Response to COVID-19 and Related Developments
• 7.6 Corium International, Inc.
  • 7.6.1 Corium International, Inc. Business Overview
  • 7.6.2 Corium International, Inc. Vaccine Delivery Devices Quarterly Production and Revenue, 2020
  • 7.6.3 Corium International, Inc. Vaccine Delivery Devices Product Introduction
  • 7.6.4 Corium International, Inc. Response to COVID-19 and Related Developments
• 7.7 3M
  • 7.7.1 3M Business Overview
  • 7.7.2 3M Vaccine Delivery Devices Quarterly Production and Revenue, 2020
  • 7.7.3 3M Vaccine Delivery Devices Product Introduction
  • 7.7.4 3M Response to COVID-19 and Related Developments
• 7.8 Corium International, Inc
  • 7.8.1 Corium International, Inc Business Overview
  • 7.8.2 Corium International, Inc Vaccine Delivery Devices Quarterly Production and Revenue, 2020
  • 7.8.3 Corium International, Inc Vaccine Delivery Devices Product Introduction
  • 7.8.4 Corium International, Inc Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

• 8.1 Vaccine Delivery Devices Supply Chain Analysis
  • 8.1.1 Vaccine Delivery Devices Supply Chain Analysis
  • 8.1.2 Covid-19 Impact on Vaccine Delivery Devices Supply Chain
• 8.2 Distribution Channels Analysis
  • 8.2.1 Vaccine Delivery Devices Distribution Channels
  • 8.2.2 Covid-19 Impact on Vaccine Delivery Devices Distribution Channels
  • 8.2.3 Vaccine Delivery Devices Distributors
• 8.3 Vaccine Delivery Devices Customers

9 Key Findings

10 Appendix

• 10.1 About Us